Monday, September 28, 2020
12:00 PM – 1:00 PM ET
Please note this Virtual program is at 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain, and 9:00AM Pacific.
Tami L. Bach, MD, PhD
Clinical Assistant Professor of Medicine
Penn Comprehensive Hemophilia Center
University of Pennsylvania
After completing the CME activity, learners should be better able to:
- Assess traditional management approaches for those with hemophilia A including the potential for immunogenicity
- Describe the mechanisms of action and efficacy and safety profiles of recently approved and emerging non-factor replacement therapies for patients with hemophilia A
- Implement individualized prophylaxis management strategies using non-factor replacement therapies based on patient characteristics
- Adopt patient-centered, shared decision-making approaches to the management of hemophilia A
This activity is designed to meet the educational needs of hematologists who treat patients with hemophilia A.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity is planned and produced in accordance with ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with hemophilia A.
CNE Credits: 1.0 ANCC Contact Hour(s)
Ultimate Medical Academy/CCM is accredited as a provider of c ontinuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at email@example.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at firstname.lastname@example.org
Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.